Publications
Publications
Show Results For
- All HBS Web
(4,352)
- Faculty Publications (674)
- 2021
- Chapter
Digital Infrastructure
By: Shane Greenstein
What determines the supply of innovative digital infrastructure and how does variance in supply shape the performance of digital services? The essay reviews research into the economic impact of deployment, innovation, and adoption of digital infrastructure. It... View Details
Keywords: Information Technology; Infrastructure; Economics; Policy; Research; Analysis; United States
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
- October 2021 (Revised November 2022)
- Case
The 2012 Spanish Labor Reform: Lifting All Boats, or Leveling Down?
By: Vincent Pons, Rafael Di Tella, Santiago Botella and Elena Corsi
Since 1978, Spain had struggled to control unemployment. The country’s labor law was protective of employees hired long-term and companies used temporary contracts as buffers. In 2012, amid economic recession and a 23.6% unemployment rate, a center-right government of... View Details
Keywords: COVID-19 Pandemic; Labor Market; Unemployment; Recession; Globalized Markets and Industries; Government Legislation; International Relations; Working Conditions; Employment; Labor Unions; Contracts; Social Issues; Public Opinion; Governing Rules, Regulations, and Reforms; Spain; European Union
- 2021
- Article
Don't Get It or Don't Spread It: Comparing Self-interested versus Prosocial Motivations for COVID-19 Prevention Behaviors
By: Jillian J. Jordan, Erez Yoeli and David Rand
COVID-19 prevention behaviors may be seen as self-interested or prosocial. Using American samples from MTurk and Prolific (total n = 6,850), we investigated which framing is more effective—and motivation is stronger—for fostering prevention behavior intentions. We... View Details
- October 2021
- Case
CrisisReady: Private Data for Public Good
By: Tarun Khanna and James Barnett
In October 2021, CRISISREADY.io considers how and if it should scale operations. View Details
- October 2021 (Revised May 2023)
- Case
Engine No. 1: An Impact Investing Firm Engages with ExxonMobil
By: Mark Kramer, Shawn Cole, Vikram S. Gandhi and T. Robert Zochowski
ExxonMobil, the world's fifth largest source of carbon emissions, remained committed to aggressively expanding its oil & gas business despite global warming. During the COVID pandemic this strategy resulted in massive losses as the price and demand for oil declined. ... View Details
- October 2021 (Revised October 2022)
- Case
The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged had contributed to the nationwide... View Details
Keywords: Opioids; Drug; Investors; Shareholder Activism; Investment Activism; Executive Compensation; Corporate Accountability; Corporate Governance; Governance Compliance; Governance Controls; Risk Management; Corporate Social Responsibility and Impact; Business and Shareholder Relations; Business and Stakeholder Relations; Legal Liability; Health Industry; Health Industry; Health Industry; United States; West Virginia; Tennessee; Ohio; Pennsylvania
- October 2021
- Teaching Note
BRAC in 2020
By: Tarun Khanna and Shreya Ramachandran
Teaching Note for HBS Case No. 721-416. View Details
- Article
Health Equity, Schooling Hesitancy, and the Social Determinants of Learning
By: Meira Levinson, Alan C. Geller, Joseph G. Allen and John D. Macomber
At least 62 million K-12 students in North America—disproportionately low-income children of color— have been physically out of school for over a year due to the COVID-19 pandemic. These children are at risk of significant academic, social, mental, and physical harm... View Details
- September 28, 2021
- Editorial
A Guide to Implementing the 4-Day Workweek
By: A.V. Whillans and Charlotte Lockhart
As organizations continue to explore a variety of flexible work options, one promising avenue is the four-day workweek: The standard 40 hours per week is reduced to 32 hours, with the same pay and the same productivity expectations. Research suggests reducing hours can... View Details
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details
- August 2021
- Case
Yummy: Delivering Value to Venezuela
By: Ayelet Israeli, Jenyfeer Martinez Buitrago and Carla Larangeira
By June 2021, Yummy had become Venezuela’s first and largest food delivery app and last-mile logistics company. In Caracas, the nation’s capital, Yummy held a 55% market share, while operations in other cities had already started to take place, including in three of... View Details
- August 2021 (Revised April 2022)
- Case
KKR
By: Jo Tango and Alys Ferragamo
In June of 2021, KKR’s executive team convened to prepare for an upcoming board meeting. From a small, three-person partnership that started in 1976 and invested only in U.S. LBOs, the firm 45 years later was a public company that employed over 1,600 people and managed... View Details
- Article
A Multi-country Test of Brief Reappraisal Interventions on Emotions During the COVID-19 Pandemic
By: Ke Wang, Amit Goldenberg, Charles Dorison, Jeremy Miller, Jennifer Lerner and James Gross
The COVID-19 pandemic is increasing negative emotions and decreasing positive emotions globally. Left unchecked, these emotional changes may have a wide array of adverse impacts. To reduce negative emotions and increase positive emotions, we will examine the impact of... View Details
Keywords: COVID-19; Emotion Regulation; Reappraisal; Interventions; Health Pandemics; Emotions; Global Range
- July 2021 (Revised September 2024)
- Case
Supreme: Remaining Cool While Pursuing Growth
By: Jill Avery, Sandrine Crener, Marie-Cecile Cervellon and Ranjit Thind
Following VF Corporation’s acquisition of cult streetwear brand Supreme, consumers and industry pundits were nervous that becoming part of a large, public corporation would put an end to Supreme’s slow and careful growth trajectory as pressure for quarterly results... View Details
- July 2021 (Revised December 2021)
- Case
Pershing Square's Pandemic Trade (A)
By: Emil N. Siriwardane, Luis M. Viceira, Dean Xu and Lucas Baker
This case explores the decision that Bill Ackman, CEO and founder of the hedge fund Pershing Square Capital, was considering in late February 2020 about hedging the exposure of the fund’s portfolio from the potential financial fallout ensuing from an extreme event like... View Details
- July 2021
- Teaching Note
Digital Transformation 2.0: CEO Elie Girard at Atos
By: Tsedal Neeley
Teaching Note for HBS Case No. 421-024. Elie Girard has taken the helm as CEO of multinational IT giant Atos to lead the company into the next era of digital transformation. Noticing that customers’ digital needs were evolving to become even more specialized and global... View Details
- July 2021
- Article
Making Medications Stick: Improving Medication Adherence by Highlighting the Personal Health Costs of Non-compliance
By: Jon M. Jachimowicz, Joe J. Gladstone, Dan Berry, Charlotte L. Kirkdale, Tracey Thornley and Adam D. Galinsky
Poor compliance of prescription medication is an ongoing public health crisis. Nearly half of patients do not take their medication as prescribed, harming their own health while also increasing public health care costs. Despite these detrimental consequences, prior... View Details
- Summer 2021
- Article
The Cost and Evolution of Quality at Cipla Ltd, 1935–2016
By: Muhammad H. Zaman and Tarun Khanna
This article examines the evolution of Indian pharmaceutical manufacturer Cipla towards producing drugs that met the quality standards of European and U.S. regulators. It employs new research in Cipla’s corporate archives, the Creating Emerging Markets database, and... View Details
- June 2021
- Teaching Note
Michael Phelps: 'It's Okay to Not Be Okay'
By: Boris Groysberg, Carin-Isabel Knoop and Michael Norris
Teaching Note for HBS Case No. 421-044. In 2020, Michael Phelps, the most decorated Olympian of all time, with 28 medals in various swimming events, was now retired. As he looked back on his 20+ year athletic career, he considered what had gone into making him the... View Details